UA107221C2 - EMULSIVE PHARMACEUTICAL COMPOSITION WITH LOW OIL CONTENT WITH PROGESTOGEN - Google Patents

EMULSIVE PHARMACEUTICAL COMPOSITION WITH LOW OIL CONTENT WITH PROGESTOGEN

Info

Publication number
UA107221C2
UA107221C2 UAA201212287A UAA201212287A UA107221C2 UA 107221 C2 UA107221 C2 UA 107221C2 UA A201212287 A UAA201212287 A UA A201212287A UA A201212287 A UAA201212287 A UA A201212287A UA 107221 C2 UA107221 C2 UA 107221C2
Authority
UA
Ukraine
Prior art keywords
emulsive
progestogen
pharmaceutical composition
oil content
low oil
Prior art date
Application number
UAA201212287A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/056548 external-priority patent/WO2011134944A2/en
Publication of UA107221C2 publication Critical patent/UA107221C2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується стерильної, готової до застосування фармацевтичної емульсійної композиції олія-у-воді для парентерального введення, яка містить: 0,015-0,5 % мас./об. прогестерону; 0,5-10 мас.%/об. олії, де олія включає щонайменше 85 мас. %/мас. тригліцериду; 0,0425-4,1 мас.%/об. фосфоліпіду; 80-99,4 мас.%/об. водного середовища; де композиція має осмотичний тиск в діапазоні 200-1000 мОсм/кг, та де емульсія містить не більше ніж 1,2 % мас./мас. поліетиленгліколь 15-гідроксистеарату.The invention relates to a sterile, ready-to-use pharmaceutical emulsion oil-in-water composition for parenteral administration, containing: 0.015-0.5% w / v. progesterone; 0.5-10 wt.% / Vol. oils, where the oil comprises at least 85 wt. % / wt. triglyceride; 0.0425-4.1 wt.% / Vol. phospholipid; 80-99.4 wt.% / Vol. aquatic environment; where the composition has an osmotic pressure in the range of 200-1000 mOsm / kg, and where the emulsion contains no more than 1.2% wt./mass. polyethylene glycol 15-hydroxystearate.

UAA201212287A 2010-04-26 2011-04-26 EMULSIVE PHARMACEUTICAL COMPOSITION WITH LOW OIL CONTENT WITH PROGESTOGEN UA107221C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32796310P 2010-04-26 2010-04-26
PCT/EP2011/056548 WO2011134944A2 (en) 2010-04-26 2011-04-26 Low-oil pharmaceutical emulsion compositions comprising progestogen

Publications (1)

Publication Number Publication Date
UA107221C2 true UA107221C2 (en) 2014-12-10

Family

ID=52680909

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201212287A UA107221C2 (en) 2010-04-26 2011-04-26 EMULSIVE PHARMACEUTICAL COMPOSITION WITH LOW OIL CONTENT WITH PROGESTOGEN

Country Status (2)

Country Link
TN (1) TN2012000505A1 (en)
UA (1) UA107221C2 (en)

Also Published As

Publication number Publication date
TN2012000505A1 (en) 2014-04-01

Similar Documents

Publication Publication Date Title
EA201291108A1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF EMULSION WITH LOW CONTENT OF OIL, CONTAINING PROGESTOGEN
PH12016500100A1 (en) Self-emulsifying composition of omega3 fatty acid
PH12017501328A1 (en) Self-emulsifying composition of ?-3 fatty acid
AR088382A1 (en) FORMULATIONS OF ETANERCEPT STABILIZED WITH XILITOL
BR112017008660A2 (en) stable protein solution formulation containing high concentration of an anti-vegf antibody
NZ595204A (en) Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
BR112014004967A2 (en) sustained release lipid preconcentrate and pharmaceutical composition
MX2013009007A (en) High protein nutritional compositions and methods of making and using same.
BR112014010347A2 (en) oil containing oxidatively stable polyunsaturated fatty acid
MX2012007246A (en) Emulsion composition.
UA116886C2 (en) Chemical stabilization of iodosulfuron-methyl sodium salt by hydroxystearates
MX364687B (en) O/w microemulsion composition.
NZ589971A (en) Emollient composition comprising glycerol, vaseline and liquid paraffin
BR112013027468A2 (en) formulation component
CL2008002933A1 (en) Use of a pharmaceutical formulation comprising a hydrophobic phase, a hydrophilic phase and at least one useful surfactant for the regulation of lipolysis in mammals.
NZ710769A (en) Liquid menthol compositions
ECSP19087144A (en) OIL-IN-WATER EMULSIONS
BR112015001627A2 (en) pharmaceutical composition, their uses and method of decreasing the frequency of urination
EA201691628A1 (en) COMPOSITION FOR PERSONAL HYGIENE
MX2014009660A (en) Anti-p-selectin antibody formulation.
AR085477A1 (en) COMPOSITION TO IMPROVE STABILITY BEFORE OXIDATION OF FUEL OILS
UA107221C2 (en) EMULSIVE PHARMACEUTICAL COMPOSITION WITH LOW OIL CONTENT WITH PROGESTOGEN
SG11201804619PA (en) Hair cosmetic
BR112014014786A2 (en) antibiotic formulations
RU2013146038A (en) COSMETIC COMPOSITION AS A WATER-IN-OIL EMULSION